Sat-18-07-2020, 21:22 PM
In Cosentyx Lilly had set itself a low bar; cross-trial comparisons suggest that two rival anti-IL-23s, Abbvie’s Skyrizi and Johnson & Johnson’s Tremfya, would have been harder for mirikizumab to beat.
|
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-17-07-2020, 20:43 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by jiml - Fri-17-07-2020, 21:14 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by JohnB - Sat-18-07-2020, 20:54 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Sun-19-07-2020, 11:25 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 06:10 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 11:41 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 12:04 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 12:07 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by D Foster - Sat-18-07-2020, 21:22 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
|
si-544 Phase 1b trial in psoriasis | Fred | 4 | 847 |
Wed-22-10-2025, 20:27 PM Last Post: Fred |
|
|
ORKA-001 for psoriasis phase 2a | Fred | 0 | 1,027 |
Mon-21-07-2025, 12:35 PM Last Post: Fred |
|
|
Hold on VYN202 phase 1b for psoriasis | Fred | 1 | 1,606 |
Thu-03-07-2025, 13:31 PM Last Post: Fred |
|
|
Zoryve for psoriasis phase 3 results | Fred | 3 | 1,977 |
Wed-11-06-2025, 14:16 PM Last Post: Fred |
|
|
Picankibart for psoriasis phase 3 study | Fred | 1 | 1,252 |
Fri-30-05-2025, 01:03 AM Last Post: mataribot |